Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Safety and clinical efficacy of GW-572016 in advanced breast cancer

Dec. 12, 2003

Disease stabilization in phase II multiple myeloma study of Panzem

Dec. 12, 2003

Vion enters research and option agreement for novel anticancer compounds

Dec. 12, 2003

Novel inhibitor of Stat3 activation with activity against hematological malignancies

Dec. 11, 2003

Antitumor efficacy of Bay-59-8862 in metastatic breast cancer

Dec. 11, 2003

Improved survival with RSR-13 plus WBRT in breast cancer patients with brain metastases

Dec. 11, 2003

Antitumor activity of E-7070 in metastatic breast cancer

Dec. 11, 2003

New phase II trials to evaluate KOS-862 for various cancers

Dec. 11, 2003

Sugen identifies potential surrogate markers for SU-11248 activity

Dec. 11, 2003

Dual-acting estrogen sulfatase inhibitor and SERM presented in San Antonio

Dec. 10, 2003

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...